Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens.
AUTOR(ES)
Jacoby, G
RESUMO
Carbapenems L-749,345 and imipenem had the lowest MICs at which 90% of isolates were inhibited (0.5 microg/ml) of 14 antimicrobial agents tested against 76 multiresistant gram-negative clinical isolates with TEM- or SHV-type extended-spectrum beta-lactamases and chromosomal or plasmid-determined AmpC beta-lactamases, but the MIC of L-749,345 for one isolate of Klebsiella pneumoniae was 16 microg/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164016Documentos Relacionados
- In Vitro Pharmacodynamic Studies of L-749,345 in Comparison with Imipenem and Ceftriaxone against Gram-Positive and Gram-Negative Bacteria
- Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
- In Vitro Activities of MK-826 (L-749,345) against 363 Strains of Anaerobic Bacteria
- Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primates.
- In vitro activities of enoxacin and 17 other antimicrobial agents against multiply resistant, gram-negative bacteria.